Loading...
Loading...
NYSE: ZBH
Healthcare · Medical - Devices
●S&P 500 since 2001
Market Cap
$17.65B
52w High
$114.44
52w Low
$84.59
P/E
24.91
Volume
2.16M
Outstanding Shares
198.18M
Valuation Data Insufficient
The DCF model's fair value estimate is more than 3× the current stock price. This typically indicates unreliable model inputs — such as irregular cash flows or balance sheet distortions — rather than a genuine opportunity, so the valuation is not shown.
Company profile
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Valuation
Stock splits
Profitability & growth
Analyst consensus
18
Buy
20
Hold
3
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 4, 2026
View
EPS
Actual vs estimate by quarter
$2.07
$1.98
$1.90
$1.87
$2.42
$2.40
—
Revenue
Actual vs estimate by quarter
$2.08B
$2.06B
$2B
$2.01B
$2.24B
$2.06B
—